JPMorgan Chase & Co’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368 | Sell |
154
-77
| -33% | -$184 | ﹤0.01% | 5839 |
|
|
2025
Q1 | $993 | Sell |
231
-106
| -31% | -$456 | ﹤0.01% | 5754 |
|
|
2024
Q4 | $2.9K | Sell |
337
-430
| -56% | -$3.7K | ﹤0.01% | 5542 |
|
|
2024
Q3 | $13K | Sell |
767
-25
| -3% | -$425 | ﹤0.01% | 5275 |
|
|
2024
Q2 | $12K | Sell |
792
-712
| -47% | -$10.8K | ﹤0.01% | 5218 |
|
|
2024
Q1 | $25K | Sell |
1,504
-114
| -7% | -$1.89K | ﹤0.01% | 5181 |
|
|
2023
Q4 | $25.9K | Buy |
1,618
+763
| +89% | +$12.2K | ﹤0.01% | 5187 |
|
|
2023
Q3 | $65.1K | Buy |
855
+84
| +11% | +$6.4K | ﹤0.01% | 4815 |
|
|
2023
Q2 | $50.6K | Sell |
771
-1,207
| -61% | -$79.2K | ﹤0.01% | 4860 |
|
|
2023
Q1 | $118K | Buy |
1,978
+31
| +2% | +$1.85K | ﹤0.01% | 4577 |
|
|
2022
Q4 | $45K | Sell |
1,947
-689
| -26% | -$15.9K | ﹤0.01% | 4777 |
|
|
2022
Q3 | $88K | Buy |
+2,636
| New | +$88K | ﹤0.01% | 4511 |
|
|
2022
Q2 | – | Sell |
-408
| Closed | -$12K | – | 5952 |
|
|
2022
Q1 | $12K | Buy |
408
+164
| +67% | +$4.82K | ﹤0.01% | 5363 |
|
|
2021
Q4 | $21K | Sell |
244
-68
| -22% | -$5.85K | ﹤0.01% | 5316 |
|
|
2021
Q3 | $23K | Sell |
312
-467
| -60% | -$34.4K | ﹤0.01% | 5115 |
|
|
2021
Q2 | $73K | Buy |
+779
| New | +$73K | ﹤0.01% | 4856 |
|